These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23676557)

  • 1. Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma.
    Nakazato Y; Maeshima AM; Ishikawa Y; Yatabe Y; Fukuoka J; Yokose T; Tomita Y; Minami Y; Asamura H; Tachibana K; Goya T; Noguchi M
    J Thorac Oncol; 2013 Jun; 8(6):736-43. PubMed ID: 23676557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis.
    Nakazato Y; Minami Y; Kobayashi H; Satomi K; Anami Y; Tsuta K; Tanaka R; Okada M; Goya T; Noguchi M
    Cancer; 2010 Apr; 116(8):2011-9. PubMed ID: 20151423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
    Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth pattern-based grading of pulmonary adenocarcinoma-Analysis of 534 cases with comparison between observers and survival analysis.
    Boland JM; Wampfler JA; Yang P; Yi ES
    Lung Cancer; 2017 Jul; 109():14-20. PubMed ID: 28577944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma--analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules.
    Boland JM; Froemming AT; Wampfler JA; Maldonado F; Peikert T; Hyland C; de Andrade M; Aubry MC; Yang P; Yi ES
    Hum Pathol; 2016 May; 51():41-50. PubMed ID: 27067781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of a newly proposed grading and scoring system in stage I pulmonary adenocarcinoma].
    Ding FG; Liu B; Zhang XH; Xu Y; Yu B; Zhang RS; He Y; Ma HH; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):145-50. PubMed ID: 22800475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas.
    Warth A; Stenzinger A; von Brünneck AC; Goeppert B; Cortis J; Petersen I; Hoffmann H; Schnabel PA; Weichert W
    Eur Respir J; 2012 Nov; 40(5):1221-7. PubMed ID: 22408209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.
    Wu TT; Chirieac LR; Abraham SC; Krasinskas AM; Wang H; Rashid A; Correa AM; Hofstetter WL; Ajani JA; Swisher SG
    Am J Surg Pathol; 2007 Jan; 31(1):58-64. PubMed ID: 17197919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
    Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
    J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic grading of invasive lobular carcinoma: does use of a 2-tiered nuclear grading system improve interobserver variability?
    Adams AL; Chhieng DC; Bell WC; Winokur T; Hameed O
    Ann Diagn Pathol; 2009 Aug; 13(4):223-5. PubMed ID: 19608079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Pääkkö P; Lappi-Blanco E; Kaarteenaho R
    Histopathology; 2017 Sep; 71(3):425-436. PubMed ID: 28401582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
    Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
    Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis.
    Minami Y; Matsuno Y; Iijima T; Morishita Y; Onizuka M; Sakakibara Y; Noguchi M
    Lung Cancer; 2005 Jun; 48(3):339-48. PubMed ID: 15893002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
    Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
    Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between Noguchi's classification for small adenocarcinomas of the lung and tumor markers in serum].
    Watanabe A; Watanabe T; Tabata T; Takahashi K; Abe T; Abe S; Sato M; Kusajima K
    Kyobu Geka; 2001 Oct; 54(11):917-20. PubMed ID: 11593727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung: potential parameters for a grading system.
    von der Thüsen JH; Tham YS; Pattenden H; Rice A; Dusmet M; Lim E; Nicholson AG
    J Thorac Oncol; 2013 Jan; 8(1):37-44. PubMed ID: 23242436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma.
    Hwang I; Park KU; Kwon KY
    Int J Surg Pathol; 2014 May; 22(3):212-20. PubMed ID: 24599899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of grading systems in stage I lung adenocarcinomas: a retrospective cohort study.
    Zombori T; Furák J; Nyári T; Cserni G; Tiszlavicz L
    J Clin Pathol; 2018 Feb; 71(2):135-140. PubMed ID: 28747392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interobserver variability for the WHO classification of pulmonary carcinoids.
    Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
    Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.